The association between proton‐pump inhibitor use and recurrence of hepatocellular carcinoma after hepatectomy

Abstract

The association between long-term proton-pump inhibitors (PPIs) use and malignancies had long been discussed, but it still lacks consensus. Our study investigated the association between PPI use and hepatocellular carcinoma (HCC) recurrence following curative surgery.